Stay updated on Immunotherapy with Chemo in HER2-neg IBC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with Chemo in HER2-neg IBC Clinical Trial page.

Latest updates to the Immunotherapy with Chemo in HER2-neg IBC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2; deleted government funding notice and Revision: v3.4.1.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding status notice and two references (Rastogi et al. 2008; Denkert et al. 2010); removed two references with errata for Rastogi et al. 2008 and Denkert et al. 2010.SummaryDifference0.4%

- Check28 days agoChange DetectedAdds a glossary toggle and new metadata labels: Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Removes the previous labels Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.0%

- Check49 days agoChange DetectedPublications section updated: two references added and two references removed (Rastogi et al. 2008 J Clin Oncol; Denkert et al. 2010 J Clin Oncol). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter now shows Revision: v3.3.3; HHS Vulnerability Disclosure link and Revision: v3.3.2 reference were removed, which are cosmetic changes that do not affect the study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy with Chemo in HER2-neg IBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with Chemo in HER2-neg IBC Clinical Trial page.